Solubility of the metastable polymorph of piracetam (Form II) in a range of solvents

Journal of Chemical and Engineering Data

Volumn 57, Issue 12, 2012, Pages 3525-3531

  Maher, Anthony ^a   Rasmuson, Åke C ^a   Croker, Denise M ^a   Hodnett, Benjamin K ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

1 ,4-DIOXANE; 2-PROPANOL; AMBIENT CONDITIONS; DIFFERENT SOLVENTS; METASTABLE FORM; PIRACETAM; POLYMORPHIC COMPOSITION; REGRESSION EQUATION; SOLID-LIQUID; SOLID-PHASE; SOLUBILITY DATA; SOLUTION CONCENTRATION; SOLVENT ACIDITIES; SOLVENT POLARITY; STABLE FORM; TEMPERATURE RANGE;

ACETONE; DIFFERENTIAL SCANNING CALORIMETRY; ETHANOL; ETHERS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MELTING POINT; ORGANIC SOLVENTS; SOLUBILITY; X RAY DIFFRACTION;

SOLVENTS;

EID: 84870782541     PISSN: 00219568     EISSN: 15205134     Source Type: Journal    
DOI: 10.1021/je300711r     Document Type: Article

References (19)

1. Gracin, A.; Rasmuson, A. C. Solubility of Phenylacetic Acid, p-Hydroxyphenylacetic Acid, p-Aminophenylacetic Acid, p-Hydroxybenzoic Acid, and Ibuprofen in Pure Solvents J. Chem. Eng. Data 2002, 47, 1379-1383
2. Cardew, P. T.; Davey, R. J. The kinetics of solvent-mediated phase transformations Proc. R. Soc. London A 1985, 398, 415-428
3. Vippaguntaa, S. R.; Brittain, H. G.; Grant, D. J. W. Crystalline solids Adv. Drug Delivery Rev. 2001, 48, 3-26
4. Bernstein, J.; Davey, R. J.; Henck, J. O. Concomitant polymorphs Angew. Chem. Int. 1999, 38, 3441-3461
5. Mullin, J. W. Crystallization, 4 th ed.; Elsevier Ltd.: New York, 2001.
6. Yu, L. X.; Furness, M. S.; Raw, A.; Outlaw, K. P. W.; Nashed, N. E.; Ramos, E.; Miller, S. P. F.; Adams, R. C.; Fang, F.; Patel, R. M.; Holcombe, F. O.; Chiu, Y.; Hussain, A. S. Scientific considerations of pharmaceutical solid polymorphism in abbreviated new drug applications Pharm. Res. 2003, 20, 531-536
7. Winbald, B. Piracetam: A Review of Pharmacological Properties and Clinical Uses CNS Drug Rev. 2005, 11, 169-182
8. Gualtieri, F.; Manetti, D.; Romanelli, M. N.; Ghelardini, C. Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing Drugs Curr. Pharm. Des. 2002, 8, 125-138
9. Maher, A.; Croker, D. M; Rasmuson, A. C.; Hodnett, B. K. The Solubility of Form III Piracetam in a Range of Solvents J. Chem. Eng. Data 2010, 55, 5314-5318
10. Allen, F. The Cambridge Structural Database: a quarter of a million crystal structures and rising Acta Crystallogr. B 2002, 58, 380-388
11. Pavlova, A. W. Polymorphisms of Piracetam Pharmazie 1979, 34, 449-450
12. Pavlova, A. W.; Konstantinova, N.; Dashkalov, H.; Georgiev, A. A study of crystalline forms of piracetam Pharmazie 1983, 38, 634
13. Kuhnert-Brandstaetter, M.; Burger, A.; Voellenklee, R. Stability behaviour of piracetam polymorphs Sci. Pharm. 1994, 62, 307-316
14. Dematos, L.; Williams, A.; Booth, S.; Petts, C.; Taylor, D.; Blagden, N. Solvent influences on metastable polymorph lifetimes: Real-time interconversions using energy dispersive X-Ray diffractometry J. Pharm. Sci. 2007, 96, 1069-1078
15. Ceolin, R.; Agafonov, V.; Louer, D.; Dzyabchenko, V. A.; Toscani, S.; Cense, J. M. Phenomenology of Polymorphism, III: p,T Diagram and Stability of Piracetam Polymorphs J. Solid State Chem. 1996, 122, 186-194
16. Picciochi, R.; Diogo, H. P.; Minas da Piedade, M. E. Thermodynamic Characterisation of Three Polymorphic Forms of Piracetam J. Pharm. Sci. 2011, 100, 594-603
17. O'Mahony, M. A.; Maher, A.; Croker, D. M.; Rasmuson, A. C.; Hodnett, B. K. Examining Solution and Solid State Composition for the Solution-Mediated Polymorphic Transformation of Carbamazepine and Piracetam Cryst. Growth Des. 2012, 12, 1925-1932
18. Pudipeddi, M.; Serajuddin, A. Trends in Solubility of Polymorphs J. Pharm. Sci. 2004, 94, 929-939
19. Nordström, F. L.; Rasmuson, A. C. Prediction of solubility curves and melting properties of organic and pharmaceutical compounds Eur. J. Pharm. Sci. 2009, 36, 330-344